Research Article Details

Article ID: A04824
PMID: 33493297
Source: Clin Infect Dis
Title: Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir.
Abstract: Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.
DOI: 10.1093/cid/ciab057